Regular ArticleDetection of Behavioral Impairments Correlated to Neurochemical Deficits in Mice Treated with Moderate Doses of 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
References (49)
- et al.
The pasta matrix reaching task: A simple test for measuring skilled reaching distance, direction, and dexterity in rats
J. Neurosci. Methods
(2001) - et al.
Atm-deficient mice: A paradigm of ataxia telangiectasia
Cell
(1996) - et al.
Development and consistency of gait in the mouse
Physiol. Behav.
(2001) - et al.
Effects of MPTP on locomotor activity in mice
Neurotoxicol. Teratol.
(1990) Behavioral phenotyping of transgenic and knockout mice: Experimental design and evaluation of general health, sensory functions, motor abilities, and specific behavioral tests
Brain Res.
(1999)- et al.
MPP(+)-induced neurotoxicity in mouse is age-dependent: Evidenced by the selective inhibition of complexes of electron transport
Brain Res.
(1996) - et al.
Time-course and dose–response study on the effects of chronic l-DOPA administration on striatal dopamine levels and dopamine transporter following MPTP toxicity
Brain Res.
(2000) - et al.
Reduced striatal vesicular monoamine transporters after neurotoxic but not after behaviorally-sensitizing doses of methamphetamine
Eur. J. Pharmacol.
(1997) - et al.
Mechanisms of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity to striatal dopamine neurons in mice
Prog. Neuropsychopharmacol. Biol. Psychiatry
(1985) - et al.
The acute effect on levels of catecholamines and metabolites in brain, of a single dose of MPTP in 8 strains of mice
Neuropharmacology
(1989)
Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Neurodegeneration
(1995)
A low-cost method to analyse footprint patterns
J. Neurosci. Methods
(1997)
Immunochemical analysis of vesicular monoamine transporter (VMAT2) protein in Parkinson's disease
Exp. Neurol.
(1999)
Spontaneous regeneration of nigrostriatal dopaminergic neurons in MPTP-treated C57BL/6 mice
Biochem. Biophys. Res. Commun.
(1998)
Short-term treatments with haloperidol or bromocriptine do not alter the density of the monoamine vesicular transporter in the substantia nigra
Neurosci. Lett.
(1994)
The overall rod performance test in the MPTP-treated-mouse model of Parkinsonism
J. Neurosci. Methods
(1998)
Behavioral phenotyping of the MPTP mouse model of Parkinson's disease
Behav. Brain Res.
(2001)
Differences in pre- and post-synaptic sensitivity to apomorphine between saline and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated C57BL/6 mice as reflected in climbing activity
Eur. J. Pharmacol.
(1998)
Chronic neurochemical and behavioral changes in MPTP-lesioned C57BL/6 mice: A model for Parkinson's disease
Brain Res.
(1990)
Knockout of the vesicular monoamine transporter 2 gene results in neonatal death and supersensitivity to cocaine and amphetamine
Neuron
(1997)
Histochemical, biochemical and behavioural consequences of MPTP treatment in C-57 black mice
Brain Res.
(1987)
Animal models of parkinsonism using selective neurotoxins: Clinical and basic implications
Int. Rev. Neurobiol.
(1989)
Age-related susceptibility to MPTP-induced neurotoxicity in mice
Neurotoxicology
(1993)
Discriminating mild parkinsonism: Methods for epidemiological research
Mov. Disord.
(2001)
Cited by (173)
Role of rodent models in advancing precision medicine for Parkinson's disease
2023, Handbook of Clinical NeurologyAltered expression of voltage gated sodium channel Nav1.1 is involved in motor ability in MPTP-treated mice
2021, Brain Research BulletinBeneficial effects of cysteamine in Thy1-α-Syn mice and induced pluripotent stem cells with a SNCA gene triplication
2020, Neurobiology of Disease
- 1
To whom correspondence should be addressed at Center for Neurodegenerative Diseases, Whitehead Biomedical Research Building, 615 Michael Street, Atlanta, GA 30322. Fax: (404) 727-3728. E-mail: [email protected].
Copyright © 2002 Elsevier Science (USA). All rights reserved.